Ocular complications after antivascular endothelial growth factor therapy in medicare patients with age-related macular degeneration

American Journal of Ophthalmology

Volumn 152, Issue 2, 2011, Pages 266-272

  Day, Shelley ^a   Acquah, Kofi ^b   Mruthyunjaya, Prithvi ^a   Grossman, Daniel S ^b   Lee, Paul P ^a   Sloan, Frank A ^b  

^a DUKE UNIVERSITY EYE CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; ANGIOGENESIS INHIBITOR; APTAMER; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; DATA BASE; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODEL; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA TEAR; RETROSPECTIVE STUDY; REVIEW; UVEITIS; VITREOUS HEMORRHAGE; ARTICLE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; EYE DISEASE; HEALTH SERVICES RESEARCH; INTRAVITREAL DRUG ADMINISTRATION; RETINA MACULA DEGENERATION; STATISTICS; UNITED STATES;

AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; APTAMERS, NUCLEOTIDE; CASE-CONTROL STUDIES; ENDOPHTHALMITIS; EYE DISEASES; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MEDICARE PART B; PROPORTIONAL HAZARDS MODELS; RETINAL DETACHMENT; RETINAL PERFORATIONS; RETROSPECTIVE STUDIES; UNITED STATES; UVEITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS HEMORRHAGE;

EID: 79960837857     PISSN: 00029394     EISSN: 18791891     Source Type: Journal    
DOI: 10.1016/j.ajo.2011.01.053     Document Type: Article

References (25)

1. D.S. Friedman, B.J. O'Colmain, and B. Munoz Prevalence of age-related macular degeneration in the United States Arch Ophthalmol 122 4 2004 564 572 (Pubitemid 38456293)
2. J.R. Evans, A.E. Fletcher, and R.P. Wormald Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community Ophthalmology 111 3 2004 513 517 (Pubitemid 38293108)
3. S. Resnikoff, D. Pascolini, and D. Etya'ale Global data on visual impairment in the year 2002 Bull World Health Organ 82 11 2004 844 851 (Pubitemid 39573742)
4. P.J. Rosenfeld, D.M. Brown, and J.S. Heier Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 14 2006 1419 1431 (Pubitemid 44511557)
5. D.M. Brown, M. Michels, P.K. Kaiser, J.S. Heier, J.P. Sy, and T. Ianchulev Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR study Ophthalmology 116 1 2009 57 65
6. D.S. Fong, P. Custis, J. Howes, and J.W. Hsu Intravitreal bevacizumab and ranibizumab for age-related macular degeneration a multicenter, retrospective study Ophthalmology 117 2 2010 298 302
7. N.M. Bressler Antiangiogenic approaches to age-related macular degeneration today Ophthalmology 116 10 Suppl 2009 S15 S23
8. I.D. Ladas, D.A. Karagiannis, A.A. Rouvas, A.I. Kotsolis, A. Liotsou, and I. Vergados Safety of repeat intravitreal injections of bevacizumab versus ranibizumab: our experience after 2,000 injections Retina 29 3 2009 313 318
9. D.R. Fintak, G.K. Shah, and K.J. Blinder Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab Retina 28 10 2008 1395 1399
10. T. Diago, C.A. McCannel, S.J. Bakri, J.S. Pulido, A.O. Edwards, and J.M. Pach Infectious endophthalmitis after intravitreal injection of antiangiogenic agents Retina 29 5 2009 601 605
11. E.S. Gragoudas, A.P. Adamis, E.T. Cunningham Jr, M. Feinsod, and D.R. Guyer Pegaptanib for neovascular age-related macular degeneration N Engl J Med 351 27 2004 2805 2816 (Pubitemid 40051904)
12. D.S. Boyer, C.Y. Chung, and L. Tuomi A safety overview of ranibizumab in patients with wet AMD: ANCHOR, MARINA, PIER, and SAILOR studies Paper presented at the AAO/SOE Joint Annual Meeting November 811, 2008 Atlanta, Georgia
13. L. Wu, M.A. Martinez-Castellanos, and H. Quiroz-Mercado Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES) Graefes Arch Clin Exp Ophthalmol 246 1 2008 81 87 (Pubitemid 350167096)
14. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 5 1987 373 383 (Pubitemid 17055592)
15. P. Rosenbaum, and D. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
16. R.B. D'Agostino Jr Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 19 1998 2265 2281 (Pubitemid 28466823)
17. S.T. Normand, M.B. Landrum, and E. Guadagnoli Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores J Clin Epidemiol 54 4 2001 387 398 (Pubitemid 32303462)
18. P.C. Austin, P. Grootendorst, and G.M. Anderson A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study Stat Med 26 4 2007 734 753 (Pubitemid 46206593)
19. L.H. Lima, S.A. Zweifel, and M. Engelbert Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy Retina 29 9 2009 1213 1217
20. A.R. Bhavsar, J.M. Googe Jr, and C.R. Stockdale Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials Arch Ophthalmol 127 12 2009 1581 1583
21. R.D. Jager, L.P. Aiello, S.C. Patel, and E.T. Cunningham Jr Risks of intravitreous injection: a comprehensive review Retina 24 5 2004 676 698 (Pubitemid 39391758)
22. X.L. Du, C.R. Key, L. Dickie, R. Darling, J.M. Geraci, and D. Zhang External validation of Medicare claims for breast cancer chemotherapy compared with medical chart reviews Med Care 44 2 2006 124 131 (Pubitemid 43755463)
23. G.S. Cooper, B. Virnig, C.N. Klabunde, N. Schussler, J. Freeman, and J.L. Warren Use of SEER-Medicare data for measuring cancer surgery Med Care 40 8 Suppl 2002 IV-43 IV-48
24. J.C. Javitt, A.M. McBean, S.S. Sastry, and F. DiPaolo Accuracy of coding in Medicare part B claims Cataract as a case study Arch Ophthalmol 111 5 1993 605 607 (Pubitemid 23143163)
25. T. Sato, K. Emi, and T. Ikeda Severe intraocular inflammation after intravitreal injection of bevacizumab Ophthalmology 117 3 2010 512 516